XERS
Xeris Pharmaceuticals Inc
9.10$
+1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.58 | 0.77 | 0.20 | 0.10 | 0.10 | 0.63 | 0.81 | 1.19 | 1.38 | 1.69 | |
| 0.00 | 0.00 | 0.00 | 0.06 | 0.06 | 0.17 | 0.17 | 0.21 | 0.25 | 0.31 | |
| 0.58 | 0.77 | 0.20 | 0.04 | 0.04 | 0.46 | 0.65 | 0.98 | 1.13 | 1.38 | |
| 5.56 | 9.94 | 3.37 | 2.31 | 2.31 | 0.32 | 0.15 | 0.16 | 0.17 | 0.18 | |
| 2.20 | 3.95 | 1.75 | 2.42 | 2.82 | 1.59 | 1.02 | 1.06 | 1.11 | 1.06 | |
| 7.76 | 13.89 | 5.13 | 4.73 | 4.73 | 1.92 | 1.25 | 1.30 | 1.36 | 1.24 | |
| -7.18 | -13.13 | -4.93 | -4.69 | -4.69 | -1.46 | -0.60 | -0.32 | -0.23 | 0.14 | |
| 0.00 | 0.00 | 0.21 | 0.27 | 0.27 | 0.09 | 0.10 | 0.19 | 0.23 | 0.17 | |
| -7.17 | -13.09 | -4.99 | -4.83 | -4.83 | -1.55 | -0.71 | -0.46 | -0.39 | 0.00 | |
| 0.00 | 0.00 | 0.15 | -0.02 | -0.02 | 0.00 | -0.01 | -0.01 | -0.02 | – | |
| -7.17 | -13.09 | -4.99 | -4.81 | -4.81 | -1.55 | -0.70 | -0.45 | -0.37 | 0.00 | |
| -7.11 | -13.00 | -4.75 | -4.58 | -4.51 | -1.44 | -0.51 | -0.17 | -0.10 | 0.07 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.